IntuBio ApS: Financial statements 2022
CVR: 39719010
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
IntuBio ApS (CVR 39719010) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,678,803 and a net result of DKK 369,556 compared with DKK 365,372 the year before. That is an increase of 17.3% compared with the year before. Equity in the 2022 report amounted to DKK 312,909. The solvency ratio was 8.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,678,803
- Profit/Loss
- DKK 369,556
- Equity
- DKK 312,909
- Total Assets
- DKK 3,833,233
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.7 mio. | 370 t. | 313 t. | 3 |
| 2021 | - | 2.3 mio. | 365 t. | -57 t. | 3 |
| 2020 | - | 406 t. | -678 t. | -422 t. | 2 |
Official annual report
Keep an eye on IntuBio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
IntuBio ApS has published its annual report for 2021. Gross profit came to DKK 2,282,759, and the net result was DKK 365,372.
About IntuBio ApS
IntuBio ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tom Olesen. The board consists of Tom Olesen (chair) and Niels Agersnap Larsen. The company's owners include FASTFLOW SYSTEMS ApS, Agersnap Technologies ApS and Famole G2 Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 2,108,009 and a net result of DKK -750,643 compared with DKK -420,888 the year before. Equity in the 2025 report amounted to DKK 620,115.